Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.

Volume 32, Number 3—March 2026

Synopsis

Stenotrophomonas maltophilia Bloodstream Infection Outbreak in Acute Care Hospital, California, USA, 2022–20231

Sana M. Khan, Axel A. Vazquez Deida, Steven Langerman, Jennifer C. Hunter, Rebeca Elliott, Alison Laufer Halpin, Alyssa G. Kent, Paige Gable, Heather A. Moulton-Meissner, Frances C. Knight, Thomas Ewing, Kristen Clancy, Amit Chitnis, Eileen F. Dunne, Dustin Heaton, Barbara Allen, Hillary Metcalf, Munira Shemsu, Kathleen Nava, Suada Abdic, Kiran M. Perkins, Elsa Villarino, Jeffrey Silvers, and Kavita K. TrivediComments to Author 
Author affiliation: Author affiliations: Centers for Disease Control and Prevention, Atlanta, Georgia, USA (S.M. Khan, A.A. Vazquez Deida, S. Langerman, J.C. Hunter, A. Laufer Halpin, A.G. Kent, P. Gable, H.A. Moulton-Meissner, F.C. Knight, T. Ewing, K. Clancy, K.M. Perkins); Alameda County Public Health Department, San Leandro, California, USA (S.M. Khan, A. Chitnis, E.F. Dunne, D. Heaton, M. Shemsu, K.K. Trivedi); California Department of Public Health, Richmond, California, USA (R. Elliott, B. Allen, H. Metcalf, E. Villarino); Sutter Health, Sacramento, California, USA (K. Nava, S. Abdic, J. Silvers)

Main Article

Table 1

Characteristics of case-patients and control patients in a Stenotrophomonas maltophilia bloodstream infection outbreak in acute care hospital, California, USA, 2022–2023*

Characteristics No. (%) case-patients, n = 13 No. (%) control-patients, n = 39
Median age, y (IQR)
45 (36.0–68.0)
64.0 (60.0–75.0)
Sex
M 9 (69.2) 27 (69.2)
F
4 (30.8)
12 (30.8)
Race
White 5 (46.2) 14 (35.9)
Black/African American 2 (15.4) 9 (23.1)
Asian 1 (7.7) 8 (20.5)
American Indian/Alaska Native 1 (7.7) 0 (0)
Native Hawaiian or other Pacific Islander 0 (0) 2 (5.1)
Other
4 (23.1)
6 (15.4)
Ethnicity
Hispanic 3 (23.0) 8 (22.2)
Non-Hispanic
10 (77.0)
28 (77.8)
No. underlying conditions†
0 6 (46.2) 9 (23.1)
1 6 (46.2) 13 (33.3)
2 1 (7.7) 10 (25.6)
3 0 (0) 4 (10.3)
4
0 (0)
3 (7.7)
Admitted to ICU from ED 12 (92.3) 36 (92.3)
Critical care bay of ED
10 (76.9)
26 (66.7)
On immunosuppressant treatments 1 (7.7) 3 (7.7)
Median no. (IQR) days between admission and positive culture collection 5 (3–10) NA

*ED, emergency department; ICU, intensive care unit; NA, not applicable. †Underlying conditions were assessed by using electronic health records and included coronary artery disease, congestive heart failure, diabetes, peripheral vascular disease, gastrointestinal disease, liver disease, chronic kidney disease, obesity, cancer, and hypertension.

Main Article

1Preliminary results were presented at the Society for Healthcare Epidemiology of America Spring Conference; April 16–19, 2024; Houston, Texas, USA.

Page created: February 06, 2026
Page updated: February 24, 2026
Page reviewed: February 24, 2026
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external